Skip to content
Sign in

NUTX · NASDAQ

Nutex Health (NUTX) Stock Price & Fundamentals

$529.22+0.89%+$4.67End-of-day price as of Oct 9, 2026

Nutex Health (NUTX) closed at $529.22 on Oct 9, 2026, up 0.89% from the previous close of $524.55.

Share price, past year

1Y +12.80%

52-week range $469.16 – $576.62. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$529.22
Sep 30, 2026$526.52
Aug 31, 2026$529.84
Jul 31, 2026$548.91
Jun 30, 2026$519.04
May 29, 2026$526.71
Apr 30, 2026$562.02
Mar 31, 2026$558.17
Feb 27, 2026$535.65
Jan 30, 2026$544.73
Dec 31, 2025$513.94
Nov 28, 2025$521.49
Oct 31, 2025$496.81

Key statistics

Market cap
$3.62B
P/E (TTM)
25.6
EPS (TTM)
$20.71
Revenue (TTM)
$846.72M
Net income (TTM)
$179.92M
Shares outstanding
6.8M
Dividend yield
—
52-week range
$469.16 – $576.62

Nutex Health's market cap is $3.62B, based on a share price of $529.22 and 6.8M shares outstanding as of Jun 30, 2026.

Financials

Nutex Health reported revenue of $875.26M for fiscal 2025, up 82.36% from fiscal 2024.

Nutex Health earned net income of $70.79M in fiscal 2025, a net margin of 8.1%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Nutex Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$875.26M+82.4%$70.79M8.1%$10.48$245.60M
FY2024ended Dec 31, 2024$479.95M+93.8%$52.10M10.9%$9.69$20.85M
FY2023ended Dec 31, 2023$247.65M+12.9%−$45.79M−18.5%−$10.39−$8.24M
FY2022ended Dec 31, 2022$219.29M−33.9%−$424.78M−193.7%−$100.36$35.97M
FY2021ended Dec 31, 2021$331.53M+21.0%$132.59M40.0%$0.7315$136.51M
FY2020ended Dec 31, 2020$274.03M+19,954.5%$105.97M38.7%$0.5985$25.48M
FY2019ended Dec 31, 2019$1.37M0.0%−$7.12M−520.8%—−$4.12M
FY2018ended Dec 31, 2018$1.37M+5,800.9%−$950.13K−69.5%—−$480.05K
FY2017ended Dec 31, 2017$23.17K—$582.06K2,512.6%——
FY2016ended Dec 31, 2016$0.00—−$7.43M———
Nutex Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$210.75M$65.84M$9.38
Q1 FY2026ended Mar 31, 2026$216.49M$46.81M$6.52
Q4 FY2025ended Dec 31, 2025$151.68M$11.83M—
Q3 FY2025ended Sep 30, 2025$267.80M$55.44M$7.76
Q2 FY2025ended Jun 30, 2025$243.99M−$17.70M−$2.95
Q1 FY2025ended Mar 31, 2025$211.79M$21.22M$3.33
Q4 FY2024ended Dec 31, 2024$257.62M$61.70M$11.12
Q3 FY2024ended Sep 30, 2024$78.80M−$8.79M−$1.72

Company profile

Name
Nutex Health Inc.
Ticker
NUTX
Exchange
NASDAQ
Industry (SEC SIC)
Services-Business Services, NEC
Headquarters
1776 Yorktown St, Suite 700, Houston, TX 77056
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001479681

Recent SEC filings

Frequently asked questions

What is Nutex Health's stock price?

Nutex Health (NUTX) closed at $529.22 on Oct 9, 2026, up 0.89% from the previous close of $524.55.

What is Nutex Health's market cap?

Nutex Health's market cap is $3.62B, based on a share price of $529.22 and 6.8M shares outstanding as of Jun 30, 2026.

How much revenue does Nutex Health make?

Nutex Health reported revenue of $875.26M for fiscal 2025, up 82.36% from fiscal 2024.

What is NUTX's P/E ratio?

Nutex Health's price-to-earnings ratio is 25.6, based on trailing twelve-month diluted EPS of $20.71.

Does Nutex Health pay a dividend?

Nutex Health's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Nutex Health Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures